Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Altimmune Inc (NASDAQ:ALT)

1.96
Delayed Data
As of Jan 12
 +0.01 / +0.51%
Today’s Change
1.51
Today|||52-Week Range
14.70
-1.51%
Year-to-Date
No recent news for Altimmune Inc.

Today’s Trading

Previous close1.95
Today’s open1.97
Day’s range1.92 - 1.97
Volume221,622
Average volume (3 months)180,283
Market cap$30.7M
Data as of 3:59pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-50.85%
P/E ratio0.1
Price/Sales40.80
Price/Book0.68

Competitors

 Today’s
change
Today’s
% change
AZRXAzurRx BioPharma Inc-0.14-3.85%
APOPCellect Biotechnolog...-0.17-1.90%
HSGXHistogenics Corp-0.14-4.79%
KMPHKemPharm Inc0.000.00%
Data as of 4:00pm ET, 01/12/2018

Financials

Next reporting dateMarch 9, 2018
EPS forecast (this quarter)-$0.50
Annual revenue (last year)$5.2M
Annual profit (last year)$193.9M
Net profit margin3,706.44%

Profile

Sector
Commercial Services
Industry
Miscellaneous Commercial Services
President, Chief Executive Officer &
Director
William Enright
CFO, Secretary &
EVP-Corporate Development
Elizabeth Adkins Czerepak
Corporate headquarters
Gaithersburg, Maryland

Forecasts